If a prescription is appropriate, we facilitate access to medication options through a medical team that can help guide your next steps
Although the effects of GLP-1 are mostly consistent with an anti-atherogenic function, GIP may have opposing effects that may be viewed as pro-atherogenic
For instance, a long-term study looking at bupropion for depression found that after two years, patients who weren't overweight to begin with had no significant weight change
To ensure that findings are generalizable, key next steps will be to replicate and extend this work with variations of the target (e.g., gender, race/ethnicity, prior attempts at weight loss, cost paid for medication) and diverse groups of participants, both in terms of participant demographics and preexisting knowledge of GLP-1s (e.g., general population, eligible patients, healthcare professionals)
doi: 10.1056/nejm198802043180506
Ozempic Raises Risk of Acute Gallbladder Disease and Inflammation Clinical trials, including that of Novo Nordisk, showed that Ozempic could double the risk of acute gallbladder disease in its users